
Investments
5Portfolio Exits
1Partners & Customers
10Service Providers
1About ResMed
ResMed (NYSE: RMD) (ASX: RMD) offers cloud-connected medical devices to transform care for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. The company's comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The company was founded in 1989 and is based in San Diego, California.

Want to inform investors similar to ResMed about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing ResMed
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find ResMed in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Research containing ResMed
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ResMed in 1 CB Insights research brief, most recently on May 26, 2021.
Latest ResMed News
May 31, 2023
News provided by Share this article Share this article The global mandibular advancement devices market size is being driven by the rising prevalence of the increasing demand for MRI equipment for diagnosing various medical conditions as cancer across the globe. The market value is anticipated to grow at a CAGR of 16.8% during the forecast period of 2023-2031. Mandibular Advancement Devices: Introduction Mandibular advancement devices (MADs) are devices used in the treatment of sleep apnoea, a sleep disorder characterized by pauses in breathing or shallow breathing during sleep. MADs are dental appliances that are designed to reposition the lower jaw (mandible) forward to maintain an open airway during sleep. The device holds the jaw in place, preventing the tongue and soft tissues in the throat from collapsing back and obstructing the airway. MADs are used as an alternative to Continuous Positive Airway Pressure (CPAP) therapy, which involves the use of a mask and air pressure to keep the airway open during sleep. MADs are generally considered more comfortable and less invasive than CPAP therapy. MADs are also used in the treatment of snoring, another sleep disorder characterized by noisy breathing during sleep. The device helps to reduce snoring by opening up the airway and reducing vibrations in the soft tissues of the throat. MADs are prescribed by dentists or sleep specialists and are customized for each patient. They are typically made from acrylic and designed to fit over the upper and lower teeth. Some MADs are adjustable, allowing for greater customization and comfort. Mandibular Advancement Devices: Application and Uses Mandibular advancement devices (MADs) are dental appliances designed to treat sleep apnea and snoring by advancing the lower jaw forward. They are custom-made by dental professionals and are worn during sleep to keep the airway open and prevent the tongue and soft tissues from collapsing and blocking the airway. Some common applications and uses of MADs include: Sleep Apnea Treatment: MADs are commonly used as a first-line treatment for mild to moderate obstructive sleep apnea (OSA) when continuous positive airway pressure (CPAP) therapy is not tolerated or preferred Snoring Treatment: MADs are also used to treat primary snoring by reducing the airway resistance caused by a narrow airway and preventing the soft tissues from vibrating during sleep Athletic Performance Enhancement: MADs have been used by athletes to improve their performance by increasing their lung capacity and oxygen intake during exercise Bruxism Treatment: MADs can be used to treat bruxism, a condition where the individual grinds their teeth during sleep TMJ Disorder Treatment: MADs can also be used to treat temporomandibular joint (TMJ) disorder by repositioning the jaw and reducing pressure on the TMJ Overall, MADs are a versatile and effective treatment option for a variety of sleep-related and dental conditions. Global Mandibular Advancement Devices Market Segmentations Market Breakup by Material Bite MAD Hospital Pharmacies Global Mandibular Advancement Devices Market Scenario The mandibular advancement devices (MAD) market growth is primarily driven by the increasing prevalence of sleep apnea and the rising awareness of its impact on overall health. MADs are a popular treatment option for sleep apnea, as they offer a non-invasive and effective way to keep the airway open during sleep. The market is expected to see continued growth as more people are diagnosed with sleep apnea and seek treatment. Additionally, advancements in technology have led to the development of more comfortable and user-friendly devices, further fuelling market growth. The market is also witnessing an increase in demand from the aging population, as sleep apnea is more prevalent among older adults. However, the high cost of these devices and the lack of reimbursement in some regions may hinder market growth in certain areas. Overall, the mandibular advancement devices market is expected to continue to grow in the coming years, driven by increasing awareness and technological advancements. Key Topics Covered:
ResMed Investments
5 Investments
ResMed has made 5 investments. Their latest investment was in Medihive as part of their Private Equity on January 1, 2023.

ResMed Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
1/27/2023 | Private Equity | Medihive | $7.61M | Yes | 1 | |
11/23/2021 | Seed | |||||
2/12/2020 | Series C - II | |||||
3/27/2019 | Series A | |||||
7/23/2009 | Series B |
Date | 1/27/2023 | 11/23/2021 | 2/12/2020 | 3/27/2019 | 7/23/2009 |
---|---|---|---|---|---|
Round | Private Equity | Seed | Series C - II | Series A | Series B |
Company | Medihive | ||||
Amount | $7.61M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 1 |
ResMed Portfolio Exits
1 Portfolio Exit
ResMed has 1 portfolio exit. Their latest portfolio exit was Nyxoah on September 09, 2020.
ResMed Acquisitions
19 Acquisitions
ResMed acquired 19 companies. Their latest acquisition was mementor on August 01, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
8/1/2022 | Seed / Angel | Acquired | 9 | |||
6/14/2022 | Acquired | 9 | ||||
10/1/2021 | Other | $0.01M | Acquired | 1 | ||
1/31/2020 | ||||||
3/7/2019 |
Date | 8/1/2022 | 6/14/2022 | 10/1/2021 | 1/31/2020 | 3/7/2019 |
---|---|---|---|---|---|
Investment Stage | Seed / Angel | Other | |||
Companies | |||||
Valuation | |||||
Total Funding | $0.01M | ||||
Note | Acquired | Acquired | Acquired | ||
Sources | 9 | 9 | 1 |
ResMed Partners & Customers
10 Partners and customers
ResMed has 10 strategic partners and customers. ResMed recently partnered with SleepScore Labs on November 11, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
11/21/2022 | Partner | United States | Digital health news, funding round up in the prior week; November 21, 2022 Delivery of this program comes via a newly formed partnership between SleepScore Labs 's EU headquarters in Dublin , Ireland , and ResMed Germany , bringing together SleepScore Labs 's sleep science and technology expertise with ResMed 's unrivaled expertise in clinical sleep diagnostics and therapies as well as their vast reach through their established `` Dein Schlaf . | 1 | |
10/1/2021 | Partner | United Kingdom | |||
1/1/2021 | Partner | United States | |||
1/15/2020 | Partner | ||||
10/8/2019 | Partner |
Date | 11/21/2022 | 10/1/2021 | 1/1/2021 | 1/15/2020 | 10/8/2019 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | United Kingdom | United States | ||
News Snippet | Digital health news, funding round up in the prior week; November 21, 2022 Delivery of this program comes via a newly formed partnership between SleepScore Labs 's EU headquarters in Dublin , Ireland , and ResMed Germany , bringing together SleepScore Labs 's sleep science and technology expertise with ResMed 's unrivaled expertise in clinical sleep diagnostics and therapies as well as their vast reach through their established `` Dein Schlaf . | ||||
Sources | 1 |
ResMed Service Providers
1 Service Provider
ResMed has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Acquired | Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | Acquired |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
ResMed Team
17 Team Members
ResMed has 17 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
Peter C. Farrell | Founder | Current | |
Name | Peter C. Farrell | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |
Compare ResMed to Competitors

Withings creates smart products and apps to help people across the world take care of their health and well-being. By extending the capabilities of an object through network resources, Withings provides access to computing and storage facility at no extra cost, turning objects into smart connected devices.

Dozee develops a contactless health monitor system that tracks patients' heart rates, respiration, and sleep patterns while they sleep. It integrates sensors under the mattress to capture, without physical contact, the minute vibrations caused by every heartbeat, respiration cycle, tremor, seizure, and change in posture. The company was founded in 2015 and is based in Bangalore, India.

Oura develops a wellness ring and application designed to help users get restful sleep. Its product, Oura Ring analyzes the body's sleep, activity levels, daily rhythms, and physiological responses. It tracks all stages of sleep for daily activity to provide practical steps for long-term improvement The company was founded in 2013 and is based in Oulu, Finland.

Whoop makes a fitness tracker that is popular with professional athletes. Whoop describes itself as a personal digital fitness and health coach and monitors sleep, strain and recovery.

MedIoTek Health Systems has a vision of a future in which mobile health technology enables patients, senior citizens and persons suffering from chronic heart/lung diseases can enjoy an improved quality of life at an affordable cost. The company offers a solution - VinCense. VinCense is a wireless health monitoring system and a patient monitoring system. If any of the vital parameters cross default or user-defined limits at any time, VinCense immediately alerts the care-providers.

EnsoData simplifies the process of reading and analyzing the human body to help diagnose conditions, starting with sleep. The company uses artificial intelligence to analyze data points collected from sensors placed throughout the entire human body to help clinicians make diagnoses. It was founded in 2015 and is based in Madison, Wisconsin.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.